STOCK TITAN

Clarivate Plc - CLVT STOCK NEWS

Welcome to our dedicated news page for Clarivate Plc (Ticker: CLVT), a resource for investors and traders seeking the latest updates and insights on Clarivate Plc.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Clarivate Plc's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Clarivate Plc's position in the market.

Rhea-AI Summary
Clarivate Plc announces winners of the 2022 Revenue Cycle Awards
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.44%
Tags
none
-
Rhea-AI Summary
Clarivate celebrates four new Nobel Laureates accurately identified as potential recipients
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.8%
Tags
none
-
Rhea-AI Summary
Yale University selects Clarivate's Ex Libris Alma and Ex Libris Primo VE for library services and discovery platforms, aiming to improve efficiencies and unify workflows. The cloud-based solution integrates AI and Linked Data, enabling users to find new insights at scale. The platform will enhance the user experience and benefit the Yale community.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.15%
Tags
none
Rhea-AI Summary
Rapid acceleration in IP creation and scientific knowledge drives growing acceptance of AI and ML in drug discovery and development. United States and Mainland China continue to lead innovation and remain at the forefront of AI technology advancement for drug discovery.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.7%
Tags
AI
-
Rhea-AI Summary
Clarivate Plc establishes an Academia & Government Innovation Incubator to drive innovation and introduce AI-powered solutions for academic users and customers. The first program focuses on better learning outcomes through the acquisition of Alethea, an AI-powered students' content engagement platform. Clarivate aims to improve learning outcomes, enhance student's content engagement, and grow library content usage.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.09%
Tags
-
Rhea-AI Summary
Clarivate Plc launches Forecast, an AI-driven tool for IP cost forecasting and budgeting. It provides IP professionals with predictive budget forecasting capabilities and integrates with IPfolio. Forecast aims to optimize IP portfolios and strategy, automating the process for faster budget approvals.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.68%
Tags
AI
Rhea-AI Summary
Clarivate Plc named 23 Citation Laureates, researchers whose work is deemed to be of Nobel class. The honorees have made significant contributions across various fields.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.68%
Tags
none
-
Rhea-AI Summary
Clarivate Plc terminates Tax Benefits Preservation Plan
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.27%
Tags
none
-
Rhea-AI Summary
Clarivate Plc releases annual G20 scorecard with dynamic data visualizations
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary
Clarivate Plc to present at Goldman Sachs Communacopia + Technology Conference on September 7, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.53%
Tags
conferences
Clarivate Plc

NYSE:CLVT

CLVT Rankings

CLVT Stock Data

4.72B
404.04M
16.65%
92.2%
5.52%
Data Processing, Hosting, and Related Services
Information
Link
United Kingdom
160 Blackfriars Road

About CLVT

clarivate analytics is the global leader in providing trusted insights and analytics to accelerate the pace of innovation. we offer some of the most trusted brands across the innovation lifecycle, including web of science™, cortellis™, derwent™, compumark™, markmonitor® and techstreet™. organizations and researchers rely on the curated knowledge bases from clarivate for information about scientific and academic research, patent analytics, pharmaceutical and biotech intelligence and ip management. an independent company with over 4,000 employees and operations in more than 100 countries, clarivate is on a bold entrepreneurial mission to help radically reduce the time from new ideas to life-changing innovations. for more information, please visit clarivate.com.